[HTML][HTML] Nucleoside analogues for chagas disease and leishmaniasis therapy: current status and future perspectives

EA Nwoke, S Lowe, F Aldabbagh, K Kalesh, H Kadri - Molecules, 2024 - mdpi.com
Chagas disease and leishmaniasis are two neglected tropical diseases that affect millions of
people in low-and middle-income tropical countries. These diseases caused by protozoan …

Novel 5′-norcarbocyclic pyrimidine derivatives as antibacterial agents

AL Khandazhinskaya, LA Alexandrova, ES Matyugina… - Molecules, 2018 - mdpi.com
A series of novel 5′-norcarbocyclic derivatives of 5-alkoxymethyl or 5-alkyltriazolyl-methyl
uracil were synthesized and the activity of the compounds evaluated against both Gram …

Investigation of 5'-norcarbocyclic nucleoside analogues as antiprotozoal and antibacterial agents

AL Khandazhinskaya, ES Matyugina, PN Solyev… - Molecules, 2019 - mdpi.com
Carbocyclic nucleosides have long played a role in antiviral, antiparasitic, and antibacterial
therapies. Recent results from our laboratories from two structurally related scaffolds have …

New Flexible Analogues of 8-Aza-7-deazapurine Nucleosides as Potential Antibacterial Agents

A Khandazhinskaya, B Eletskaya, A Mironov… - International Journal of …, 2023 - mdpi.com
A variety of ribo-, 2′-deoxyribo-, and 5′-norcarbocyclic derivatives of the 8-aza-7-
deazahypoxanthine fleximer scaffolds were designed, synthesized, and screened for …

Evaluation of the antiprotozoan properties of 5′-norcarbocyclic pyrimidine nucleosides

KJ Alzahrani, ES Matyugina… - Bioorganic & medicinal …, 2017 - Elsevier
Carbocyclic nucleoside analogues have a distinguished history as anti-infectious agents,
including key antiviral agents. Toxicity was initially a concern but this was reduced by the …

Structure-activity evaluation of new uracil-based non-nucleoside inhibitors of HIV reverse transcriptase

ES Matyugina, VT Valuev-Elliston, AN Geisman… - …, 2013 - pubs.rsc.org
A new series of potential nonnucleoside inhibitors of HIV-1 reverse transcriptase (NNRTIs)
based on the carbocyclic 5′-nor-uracil scaffold were designed and synthesized. Three …

[HTML][HTML] Evaluation of the Antiviral Potential of Modified Heterocyclic Base and 5'-Norcarbocyclic Nucleoside Analogs Against SARS-CoV-2

ES Matyugina, MS Novikov, LI Kozlovskaya… - Acta …, 2021 - ncbi.nlm.nih.gov
The pandemic caused by the novel betacoronavirus SARS-CoV-2 has already claimed more
than 3.5 million lives. Despite the development and use of anti-COVID-19 vaccines, the …

5-arylaminouracil derivatives as potential dual-action agents

ES Matyugina, MS Novikov, DA Babkov… - Acta Naturae …, 2015 - cyberleninka.ru
Several 5-aminouracil derivatives that have previously been shown to inhibit Mycobacterium
tuberculosis growth at concentrations of 5-40 μg/mL are demonstrated to act also as …

5′-Norcarbocyclic nucleoside analogs

ES Matyugina, AL Khandazhinskaya - Russian Chemical Bulletin, 2014 - Springer
The present review briefly outlines main methods for the synthesis of 5′-norcarbocyclic
nucleoside analogs and the biological activity spectrum of these compounds. Antiviral …

[PDF][PDF] Новые аналоги нуклеозидов в качестве прототипов антивирусных и антибактериальных агентов

АЛ Хандажинская - 2022 - ibch.ru
Актуальность темы исследования. Одной из основных задач физико-химической
биологии и медицинской химии является создание новых эффективных препаратов …